指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气

实施法国医院获得性肺炎预防与治疗推荐:一项集群随机试验

Implementation of French Recommendations for the Prevention and the Treatment of Hospital-acquired Pneumonia: A Cluster-randomized Trial.
指南 / 共识 · Clin Infect Dis · 2021-01-01
一句话结论法国医院获得性肺炎指南发布与ICU停留时间缩短相关,但审计反馈未进一步改善结局。

该研究在30家医院35个ICU开展,纳入连续成人ICU住院≥3天患者,共1856例,分基线期(602例)、审计期(669例)和干预期(585例)。审计期后按ICU集群随机分为审计反馈干预组或参加国家登记对照,主要终点为ICU停留时间。干预组依从性复合指标47%(IQR 38-56%)vs 对照组42%(IQR 25-53%)(P=0.001);与基线期相比,干预期ICU停留时间缩短3.2天(P=0.07),对照期缩短2.8天(P=0.02);干预组与对照组ICU停留时间分别为9天(IQR 5-20)和7天(IQR 5-14)(P=0.10)。结论:法国HAP指南发布与ICU停留时间缩短相关,但审计反馈未进一步改善结局。

要点

  • 在35个ICU、1856例成人患者中,法国HAP指南发布后干预期ICU停留时间较基线期缩短3.2天(P=0.07),对照期缩短2.8天(P=0.02)。
  • 审计反馈干预组依从性复合指标47%(IQR 38-56%)高于对照组42%(IQR 25-53%)(P=0.001)。
  • 干预组ICU停留时间9天(IQR 5-20)vs 对照组7天(IQR 5-14),差异未达统计学显著(P=0.10)。
  • 校正基线不平衡特征后,对照组活着转出ICU的风险比HR 1.17(95%CI 0.69-2.01;P=0.10),未达统计学显著。
  • 作者结论:指南发布与ICU停留时间缩短相关,但实施审计未进一步改善结局。

适用人群与场景

  • 30家医院35个ICU中连续纳入的成人患者,ICU住院时间≥3天。

研究设计与关键结果

  • 研究类型:集群随机试验,35个ICU(30家医院),纳入1856例成人ICU住院≥3天患者;基线期602例、审计期669例、干预期585例。
  • 干预:审计期后ICU集群随机分为审计反馈干预组或参加国家登记对照;主要终点为ICU停留时间。
  • 依从性复合指标:干预组47%(IQR 38-56%)vs 对照组42%(IQR 25-53%)(P=0.001)。
  • 与基线期相比,ICU停留时间干预期缩短3.2天(P=0.07),对照期缩短2.8天(P=0.02)。
  • ICU停留时间:对照组7天(IQR 5-14)vs 干预组9天(IQR 5-20)(P=0.10)。
  • 校正基线不平衡特征后,对照组活着转出ICU的HR 1.17(95%CI 0.69-2.01;P=0.10),未达统计学显著。

证据类型、等级与局限

  • 证据类型:集群随机试验(NCT03348579)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:法国HAP指南发布与ICU停留时间缩短相关,但实施审计以改善其应用未进一步改善结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We determined whether an audit on the adherence to guidelines for hospital-acquired pneumonia (HAP) can improve the outcomes of patients in intensive care units (ICUs).

METHODS: This study was conducted at 35 ICUs in 30 hospitals. We included consecutive, adult patients hospitalized in ICUs for 3 days or more. After a 3-month baseline period followed by the dissemination of recommendations, an audit on the compliance to recommendations (audit period) was followed by a 3-month cluster-randomized trial. We randomly assigned ICUs to either receive audit and feedback (intervention group) or participate in a national registry (control group). The primary outcome was the duration of ICU stay.

RESULTS: Among 1856 patients enrolled, 602, 669, and 585 were recruited in the baseline, audit, and intervention periods, respectively. The composite measures of compliance were 47% (interquartile range [IQR], 38-56%) in the intervention group and 42% (IQR, 25-53%) in the control group (P = .001). As compared to the baseline period, the ICU lengths of stay were reduced by 3.2 days in the intervention period (P = .07) and by 2.8 days in the control period (P = .02). The durations of ICU stay were 7 days (IQR, 5-14 days) in the control group and 9 days (IQR, 5-20 days) in the intervention group (P = .10). After adjustment for unbalanced baseline characteristics, the hazard ratio for being discharged alive from the ICU in the control group was 1.17 (95% confidence interval, .69-2.01; P = .10).

CONCLUSIONS: The publication of French guidelines for HAP was associated with a reduction of the ICU length of stay. However, the realization of an audit to improve their application did not further improve outcomes.

CLINICAL TRIALS REGISTRATION: NCT03348579.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

参考来源

  1. Roquilly A, Chanques G, Lasocki S, et al. Implementation of French Recommendations for the Prevention and the Treatment of Hospital-acquired Pneumonia: A Cluster-randomized Trial. Clin Infect Dis. 2021. PMID: 32970811. doi:10.1093/cid/ciaa1441

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。